Get started
Author

Massimiliano Salati

MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
2020 · Margherita Ratti, Andrea Lampis, et al. · Targeted Oncology · 607
PDF
Association of Obesity With Survival Outcomes in Patients With Cancer
2021 · Fausto Petrelli, Alessio Cortellini, et al. · JAMA Network Open · 530
PDF
Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
2022 · Giovanni Fucà, Romain Cohen, et al. · Journal for ImmunoTherapy of Cancer · 127
PDF
Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC?
2018 · Andrea Botticelli, Bruna Cerbelli, et al. · Journal of Translational Medicine · 123
PDF
The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors
2021 · Francesca Corti, Sara Lonardi, et al. · European Journal of Cancer · 117
Medical treatment for cholangiocarcinoma
2019 · Jorge Adeva, Bruno Sangro, et al. · Liver International · 96
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
2025 · Jesus M. Banales, Pedro M. Rodrigues, et al. · Nature Reviews Gastroenterology & Hepatology · 92
PDF
Gastric cancer: Translating novels concepts into clinical practice
2019 · Massimiliano Salati, Giulia Orsi, et al. · Cancer Treatment Reviews · 85
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
2021 · Sergio Muñoz-Martínez, Victor Sapena, et al. · JHEP Reports · 63
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab
2019 · Andrea Botticelli, Massimiliano Salati, et al. · Journal of Translational Medicine · 61
PDF
The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer
2019 · Massimiliano Salati, Roberto Filippi, et al. · Liver International · 58
Noncoding RNA in Cholangiocarcinoma
2018 · Massimiliano Salati, Chiara Braconi · Seminars in Liver Disease · 56
PDF
Stevens–Johnson syndrome during nivolumab treatment of NSCLC
2017 · M. Salati, M. Pifferi, et al. · Annals of Oncology · 53
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden
2020 · Filippo Pietrantonio, Fotios Loupakis, et al. · The Oncologist · 51
Epidemiological Overview of Hodgkin Lymphoma Across the Mediterranean Basin
2014 · Massimiliano Salati, Marina Cesaretti, et al. · Mediterranean Journal of Hematology and Infectious Diseases · 49
PDF
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers
2020 · Elizabeth C Smyth, Georgios Vlachogiannis, et al. · Gut · 47
PDF
Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?
2017 · Massimiliano Salati, Katia Di Emidio, et al. · ESMO Open · 42
PDF
Modulation of Biliary Cancer Chemo‐Resistance Through MicroRNA‐Mediated Rewiring of the Expansion of CD133+ Cells
2019 · Pietro Carotenuto, Somaieh Hedayat, et al. · Hepatology · 40
PDF
Cancer incidence, mortality, and survival in Eastern Libya: updated report from the Benghazi Cancer Registry
2015 · Mufid El Mistiri, Massimiliano Salati, et al. · Annals of Epidemiology · 39
Early Onset Metastatic Colorectal Cancer: Current Insights and Clinical Management of a Rising Condition
2023 · Bianca Medici, Beatrice Riccò, et al. · Cancers · 38
PDF
Integrated Genomics Identifies miR-181/TFAM Pathway as a Critical Driver of Drug Resistance in Melanoma
2021 · Anna Barbato, Antonella Iuliano, et al. · International Journal of Molecular Sciences · 38
PDF
IDH Signalling Pathway in Cholangiocarcinoma: From Biological Rationale to Therapeutic Targeting
2020 · Massimiliano Salati, Francesco Caputo, et al. · Cancers · 38
PDF
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience
2022 · A. Boccaccino, B. Borelli, et al. · ESMO Open · 35
PDF
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives
2023 · Giulia Grizzi, Massimiliano Salati, et al. · International Journal of Molecular Sciences · 32
PDF
NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity
2019 · Massimiliano Salati, Cinzia Baldessari, et al. · Critical Reviews in Oncology/Hematology · 32
Works count: 178
Citation count: 3,459
H-index: 28
I10-index: 63
Year
Topic
Type